Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cooper

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Oncoimmunology|April 9, 2016
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacityMarie-Andrée Forget, Cara Haymaker, Jennifer B Dennison, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptorDrew C Deniger, Kirsten Switzer, Tiejuan Mi, et al.
Cancer Research|November 17, 2006
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cellsClaudia M Kowolik, Max S Topp, Sergio Gonzalez, et al.
Plos One|August 23, 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ TumorsRadhika Thokala, Simon Olivares, Tiejuan Mi, et al.
Scientific Reports|March 29, 2014
Tumor lysing genetically engineered T cells loaded with multi-modal imaging agentsParijat Bhatnagar, Mian Alauddin, James A Bankson, et al.
Leukemia|October 17, 2006
Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cellsT Numbenjapon, L M Serrano, H Singh, et al.
Cancer Research|April 29, 2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignanciesJeff K Davies, Harjeet Singh, Helen Huls, et al.
Human Gene Therapy|November 24, 2011
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignanciesPartow Kebriaei, Helen Huls, Bipulendu Jena, et al.
Journal of Immunological Methods|July 1, 2005
A quantitative high-throughput chemotaxis assay using bioluminescent reporter cellsReena P Vishwanath, Christine E Brown, Jamie R Wagner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromesZhuang Zuo, Sourindra Maiti, Shimin Hu, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Oncoimmunology|April 9, 2016
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacityMarie-Andrée Forget, Cara Haymaker, Jennifer B Dennison, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptorDrew C Deniger, Kirsten Switzer, Tiejuan Mi, et al.
Cancer Research|November 17, 2006
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cellsClaudia M Kowolik, Max S Topp, Sergio Gonzalez, et al.
Plos One|August 23, 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ TumorsRadhika Thokala, Simon Olivares, Tiejuan Mi, et al.
Scientific Reports|March 29, 2014
Tumor lysing genetically engineered T cells loaded with multi-modal imaging agentsParijat Bhatnagar, Mian Alauddin, James A Bankson, et al.
Leukemia|October 17, 2006
Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cellsT Numbenjapon, L M Serrano, H Singh, et al.
Cancer Research|April 29, 2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignanciesJeff K Davies, Harjeet Singh, Helen Huls, et al.
Human Gene Therapy|November 24, 2011
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignanciesPartow Kebriaei, Helen Huls, Bipulendu Jena, et al.
Journal of Immunological Methods|July 1, 2005
A quantitative high-throughput chemotaxis assay using bioluminescent reporter cellsReena P Vishwanath, Christine E Brown, Jamie R Wagner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromesZhuang Zuo, Sourindra Maiti, Shimin Hu, et al.
Pageof 16